Financeira Alfa SA CFI
BOVESPA:CRIV4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Financeira Alfa SA CFI
BOVESPA:CRIV4
|
BR |
|
I
|
Innovita Biological Technology Co Ltd
SSE:688253
|
CN |
Income Statement
Income Statement
Financeira Alfa SA CFI
| Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Net Interest Income |
(6)
|
(12)
|
83
|
96
|
158
|
161
|
129
|
55
|
47
|
152
|
205
|
326
|
352
|
293
|
223
|
273
|
262
|
287
|
258
|
207
|
347
|
327
|
519
|
572
|
494
|
519
|
393
|
304
|
451
|
343
|
386
|
395
|
291
|
318
|
380
|
454
|
414
|
495
|
458
|
446
|
452
|
|
| Interest Income |
375
|
411
|
547
|
582
|
638
|
638
|
614
|
559
|
569
|
684
|
731
|
828
|
839
|
756
|
651
|
667
|
619
|
613
|
567
|
505
|
640
|
623
|
820
|
872
|
779
|
788
|
629
|
500
|
647
|
518
|
589
|
637
|
633
|
812
|
1 039
|
1 341
|
1 473
|
1 764
|
1 890
|
1 994
|
2 103
|
|
| Interest Expense |
381
|
422
|
463
|
486
|
480
|
477
|
484
|
504
|
522
|
532
|
526
|
502
|
487
|
463
|
428
|
394
|
357
|
326
|
309
|
297
|
293
|
296
|
301
|
300
|
286
|
269
|
236
|
196
|
197
|
175
|
203
|
242
|
342
|
494
|
660
|
888
|
1 059
|
1 269
|
1 432
|
1 548
|
1 652
|
|
| Non Interest Income |
386
|
370
|
313
|
325
|
235
|
311
|
317
|
397
|
366
|
421
|
415
|
318
|
240
|
307
|
299
|
323
|
235
|
276
|
331
|
285
|
173
|
274
|
212
|
217
|
167
|
160
|
159
|
169
|
31
|
125
|
113
|
158
|
210
|
282
|
297
|
204
|
65
|
87
|
49
|
80
|
71
|
|
| Revenue |
380
N/A
|
358
-6%
|
396
+11%
|
421
+6%
|
393
-7%
|
472
+20%
|
446
-6%
|
452
+1%
|
413
-9%
|
573
+39%
|
620
+8%
|
644
+4%
|
591
-8%
|
600
+1%
|
522
-13%
|
596
+14%
|
497
-17%
|
563
+13%
|
589
+5%
|
492
-16%
|
520
+6%
|
601
+16%
|
731
+22%
|
788
+8%
|
661
-16%
|
679
+3%
|
552
-19%
|
473
-14%
|
481
+2%
|
467
-3%
|
498
+7%
|
553
+11%
|
502
-9%
|
600
+20%
|
677
+13%
|
658
-3%
|
479
-27%
|
582
+22%
|
507
-13%
|
526
+4%
|
522
-1%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Loan Loss Provision |
(14)
|
(6)
|
(14)
|
(24)
|
(20)
|
(23)
|
(25)
|
(31)
|
(41)
|
(43)
|
(50)
|
(53)
|
(44)
|
(43)
|
(33)
|
(9)
|
(7)
|
(5)
|
(5)
|
(16)
|
(2)
|
(3)
|
(5)
|
(8)
|
(27)
|
(29)
|
(33)
|
(33)
|
(30)
|
(31)
|
(33)
|
(31)
|
(23)
|
(26)
|
(23)
|
(23)
|
(47)
|
(51)
|
(64)
|
(75)
|
(94)
|
|
| Non Interest Expense |
(333)
|
(333)
|
(361)
|
(363)
|
(327)
|
(403)
|
(368)
|
(365)
|
(316)
|
(470)
|
(508)
|
(527)
|
(483)
|
(489)
|
(415)
|
(490)
|
(381)
|
(445)
|
(468)
|
(377)
|
(413)
|
(498)
|
(624)
|
(668)
|
(526)
|
(538)
|
(415)
|
(357)
|
(376)
|
(362)
|
(386)
|
(410)
|
(354)
|
(445)
|
(540)
|
(564)
|
(381)
|
(507)
|
(425)
|
(418)
|
(419)
|
|
| Pre-Tax Income |
33
N/A
|
18
-45%
|
21
+16%
|
34
+62%
|
46
+34%
|
47
+1%
|
53
+14%
|
57
+6%
|
56
0%
|
59
+5%
|
61
+3%
|
64
+3%
|
64
+0%
|
67
+5%
|
74
+11%
|
97
+30%
|
109
+13%
|
113
+4%
|
117
+3%
|
99
-15%
|
105
+6%
|
100
-4%
|
102
+2%
|
112
+9%
|
108
-3%
|
112
+3%
|
104
-7%
|
84
-19%
|
75
-10%
|
75
-1%
|
80
+8%
|
112
+39%
|
124
+11%
|
129
+4%
|
114
-12%
|
71
-38%
|
50
-29%
|
25
-51%
|
18
-27%
|
34
+88%
|
9
-74%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
24
|
31
|
24
|
9
|
(5)
|
(6)
|
(10)
|
(13)
|
(14)
|
(16)
|
(18)
|
(20)
|
(20)
|
(21)
|
(26)
|
(36)
|
(39)
|
(39)
|
(38)
|
(30)
|
(32)
|
(31)
|
(32)
|
(35)
|
(31)
|
(33)
|
(29)
|
(20)
|
(21)
|
(22)
|
(24)
|
(38)
|
(45)
|
(46)
|
(41)
|
(22)
|
(12)
|
(2)
|
2
|
(0)
|
14
|
|
| Income from Continuing Operations |
58
|
49
|
45
|
43
|
41
|
41
|
43
|
43
|
43
|
43
|
44
|
44
|
44
|
46
|
48
|
61
|
69
|
74
|
79
|
70
|
73
|
69
|
70
|
77
|
77
|
79
|
75
|
64
|
54
|
53
|
57
|
73
|
79
|
84
|
73
|
49
|
39
|
22
|
20
|
33
|
23
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
1
|
1
|
(2)
|
(4)
|
|
| Net Income (Common) |
53
N/A
|
45
-16%
|
41
-9%
|
39
-4%
|
37
-6%
|
37
+0%
|
39
+5%
|
40
+1%
|
39
-1%
|
40
+1%
|
40
+1%
|
40
0%
|
40
+1%
|
42
+4%
|
44
+5%
|
57
+29%
|
65
+14%
|
70
+7%
|
74
+7%
|
65
-13%
|
68
+5%
|
64
-6%
|
65
+1%
|
72
+11%
|
72
N/A
|
74
+3%
|
70
-6%
|
58
-17%
|
54
-7%
|
52
-5%
|
54
+5%
|
70
+29%
|
77
+11%
|
80
+4%
|
75
-7%
|
54
-29%
|
39
-28%
|
26
-33%
|
20
-21%
|
31
+54%
|
19
-41%
|
|
| EPS (Diluted) |
0.5
N/A
|
0.42
-16%
|
0.38
-10%
|
0.36
-5%
|
0.35
-3%
|
0.35
N/A
|
0.37
+6%
|
0.37
N/A
|
0.38
+3%
|
0.38
N/A
|
0.39
+3%
|
0.4
+3%
|
0.39
-3%
|
0.41
+5%
|
0.43
+5%
|
0.55
+28%
|
0.63
+15%
|
0.68
+8%
|
0.72
+6%
|
0.63
-12%
|
0.66
+5%
|
0.62
-6%
|
0.63
+2%
|
0.7
+11%
|
0.7
N/A
|
0.72
+3%
|
0.68
-6%
|
0.56
-18%
|
0.53
-5%
|
0.5
-6%
|
0.53
+6%
|
0.68
+28%
|
0.75
+10%
|
0.79
+5%
|
0.73
-8%
|
0.53
-27%
|
0.38
-28%
|
0.25
-34%
|
0.2
-20%
|
0.31
+55%
|
0.18
-42%
|
|